S&P 500   3,778.51 (+2.72%)
DOW   30,209.96 (+2.44%)
QQQ   281.10 (+2.77%)
AAPL   145.48 (+2.13%)
MSFT   247.82 (+2.94%)
META   140.04 (+1.03%)
GOOGL   101.28 (+2.68%)
AMZN   120.80 (+4.25%)
TSLA   248.17 (+2.38%)
NVDA   131.09 (+4.77%)
NIO   16.64 (+7.42%)
BABA   84.15 (+4.60%)
AMD   67.81 (+2.57%)
T   16.04 (+0.88%)
MU   53.98 (+4.37%)
CGC   3.12 (+7.22%)
F   12.28 (+7.06%)
GE   67.18 (+5.63%)
DIS   100.73 (+3.71%)
AMC   7.75 (+12.65%)
PYPL   92.50 (+6.10%)
PFE   44.33 (+0.43%)
NFLX   238.74 (-0.13%)
S&P 500   3,778.51 (+2.72%)
DOW   30,209.96 (+2.44%)
QQQ   281.10 (+2.77%)
AAPL   145.48 (+2.13%)
MSFT   247.82 (+2.94%)
META   140.04 (+1.03%)
GOOGL   101.28 (+2.68%)
AMZN   120.80 (+4.25%)
TSLA   248.17 (+2.38%)
NVDA   131.09 (+4.77%)
NIO   16.64 (+7.42%)
BABA   84.15 (+4.60%)
AMD   67.81 (+2.57%)
T   16.04 (+0.88%)
MU   53.98 (+4.37%)
CGC   3.12 (+7.22%)
F   12.28 (+7.06%)
GE   67.18 (+5.63%)
DIS   100.73 (+3.71%)
AMC   7.75 (+12.65%)
PYPL   92.50 (+6.10%)
PFE   44.33 (+0.43%)
NFLX   238.74 (-0.13%)
S&P 500   3,778.51 (+2.72%)
DOW   30,209.96 (+2.44%)
QQQ   281.10 (+2.77%)
AAPL   145.48 (+2.13%)
MSFT   247.82 (+2.94%)
META   140.04 (+1.03%)
GOOGL   101.28 (+2.68%)
AMZN   120.80 (+4.25%)
TSLA   248.17 (+2.38%)
NVDA   131.09 (+4.77%)
NIO   16.64 (+7.42%)
BABA   84.15 (+4.60%)
AMD   67.81 (+2.57%)
T   16.04 (+0.88%)
MU   53.98 (+4.37%)
CGC   3.12 (+7.22%)
F   12.28 (+7.06%)
GE   67.18 (+5.63%)
DIS   100.73 (+3.71%)
AMC   7.75 (+12.65%)
PYPL   92.50 (+6.10%)
PFE   44.33 (+0.43%)
NFLX   238.74 (-0.13%)
S&P 500   3,778.51 (+2.72%)
DOW   30,209.96 (+2.44%)
QQQ   281.10 (+2.77%)
AAPL   145.48 (+2.13%)
MSFT   247.82 (+2.94%)
META   140.04 (+1.03%)
GOOGL   101.28 (+2.68%)
AMZN   120.80 (+4.25%)
TSLA   248.17 (+2.38%)
NVDA   131.09 (+4.77%)
NIO   16.64 (+7.42%)
BABA   84.15 (+4.60%)
AMD   67.81 (+2.57%)
T   16.04 (+0.88%)
MU   53.98 (+4.37%)
CGC   3.12 (+7.22%)
F   12.28 (+7.06%)
GE   67.18 (+5.63%)
DIS   100.73 (+3.71%)
AMC   7.75 (+12.65%)
PYPL   92.50 (+6.10%)
PFE   44.33 (+0.43%)
NFLX   238.74 (-0.13%)
OTCMKTS:PTEO

Proteo - PTEO Stock Forecast, Price & News

$0.09
0.00 (0.00%)
(As of 09/27/2022)
Add
Compare
Today's Range
$0.09
$0.09
50-Day Range
$0.09
$0.09
52-Week Range
$20.00
$698.00
Volume
N/A
Average Volume
11 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Proteo

Proteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The company focuses on the development of pharmaceuticals based on Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands for use in the treatment of post-surgery damage to tissue; complications resulting from organ transplantation; pulmonary hypertension; and injuries caused by accidents, cardiac infarction, and other diseases. It has a license and collaboration agreement with ARTES Biotechnology GmbH to produce Elafin by using the sublicensed yeast HANSENULA POLYMORPHA. The company was founded in 1992 and is based in Irvine, California.

Receive PTEO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Proteo and its competitors with MarketBeat's FREE daily newsletter.

PTEO Stock News Headlines

PTEO Pre-Market Quotes
Proteo Inc
PTEO.PK - Proteo Inc Profile | Reuters
See More Headlines
Receive PTEO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Proteo and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:PTEO
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Prof. Oliver Wiedow (Age 63)
    Pres, CEO, CFO & Director
  • Ms. Birge Bargmann (Age 60)
    Chief Exec. Officer of Proteo Biotech AG
    Comp: $25k
  • Dr. Juergen Michael Paal (Age 49)
    Chief Operating Officer of Proteo Biotech AG
    Comp: $36k
  • Dr. Barbara Kahlke M.D. (Age 56)
    Ph.D., Sec.













PTEO Stock - Frequently Asked Questions

How have PTEO shares performed in 2022?

Proteo's stock was trading at $0.0899 on January 1st, 2022. Since then, PTEO shares have increased by 0.0% and is now trading at $0.0899.
View the best growth stocks for 2022 here
.

What other stocks do shareholders of Proteo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Proteo investors own include Trigon Metals (TM), ShotSpotter (SSTI), PagSeguro Digital (PAGS), Kaya (KAYS) and Energizer (ENR).

What is Proteo's stock symbol?

Proteo trades on the OTCMKTS under the ticker symbol "PTEO."

How do I buy shares of Proteo?

Shares of PTEO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Proteo's stock price today?

One share of PTEO stock can currently be purchased for approximately $0.09.

How can I contact Proteo?

Proteo's mailing address is 2102 Business Center Dr, IRVINE, CA 92612-1001, United States. The official website for the company is proteo.us. The company can be reached via phone at +1-949-2534616.

This page (OTCMKTS:PTEO) was last updated on 10/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.